+54.7%
AME vs SBAC
-7.2%
+61.9%
-23.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.5% | -1.1% | +2.6% | +1.5% |
| 7D | +0.6% | -0.8% | +1.4% | +0.6% |
| 30D | -6.7% | +6.9% | -13.6% | -6.9% |
| 3M | +4.1% | -8.2% | +12.3% | +4.6% |
| 6M | +1.6% | -1.6% | +3.2% | +1.9% |
| YTD | +16.1% | -0.1% | +16.3% | +16.4% |
| 1Y | +27.3% | -0.5% | +27.8% | +27.6% |
| All | +54.7% | -7.2% | +61.9% | +51.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling